Surface functionalisation of encoded SU-8 microparticles and their uses in multiplexed suspension biological assays

Recently, a novel diffractive-based encoded system has been developed for various multiplexed suspension biological assays. These microparticles, which are manufactured using photolithography of a commercial epoxy-based negative photoresist (SU-8), contain micrometre-sized diffractive elements and c...

Full description

Bibliographic Details
Main Author: She, Joseph K.
Other Authors: Roach, Peter
Published: University of Southampton 2011
Subjects:
543
Online Access:https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.548245
Description
Summary:Recently, a novel diffractive-based encoded system has been developed for various multiplexed suspension biological assays. These microparticles, which are manufactured using photolithography of a commercial epoxy-based negative photoresist (SU-8), contain micrometre-sized diffractive elements and can encode millions of unique codes. In this thesis, the preparation and surface modification of different diffractive microparticles; the attachment of a range of biological molecules (e.g. proteins and peptides) onto the functionalised surfaces; and different on-bead analytical techniques for surface characterisation are described. From a thermodynamic study of a multiplexed immunoassay for immunoglobulins (Ig, MW ~150 kDa), the immobilised probe molecules exhibit high affinity (Kd = 9 ± 3 nM) and excellent specificity (S/N >36:1) for the target analytes. The suspension assay resembles solution-like reaction kinetics allowing detection of multiple target proteins in <20 min. The encoded microparticles can also be used for quantifying small proteins, such as cytokines (MW ~20 kDa). In a particle-based sandwich suspension immunoassay, human tumour necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6) are detected and compared with conventional enzyme-linked immunosorbent assays (ELISA). Correlation coefficients (R2) for the two cytokines are found to be >0.96. Intra-assay variability (%CV) is determined to be <25%. The sensitivity of the multiplexed immunoassay, expressed as Lowest Detection Limit (LDL), is found to be 379 fM and 1.47 pM for TNF-α and IL-6 respectively, and are comparable to the corresponding ELISAs as demonstrated by the suppliers